000 01045 a2200337 4500
005 20250514052159.0
264 0 _c20030107
008 200301s 0 0 eng d
022 _a0091-3952
040 _aNLM
_beng
_cNLM
100 1 _aHorstink, Martin W I M
245 0 0 _aEstrogen and Parkinson's disease.
_h[electronic resource]
260 _bAdvances in neurology
_c2003
300 _a107-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aEstrogens
_xdeficiency
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMenopause
_xphysiology
650 0 4 _aMenstrual Cycle
_xphysiology
650 0 4 _aNeuroprotective Agents
_xtherapeutic use
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aSex Characteristics
650 0 4 _aSubstantia Nigra
_xdrug effects
700 1 _aStrijks, Elma
700 1 _aDluzen, Dean E
773 0 _tAdvances in neurology
_gvol. 91
_gp. 107-14
999 _c12249264
_d12249264